PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 87 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,950 | -44.8% | 176,837 | -8.6% | 0.00% | -33.3% |
| Q2 2023 | $5,344 | -60.2% | 193,439 | -66.9% | 0.00% | -50.0% |
| Q1 2023 | $13,427 | +382.8% | 583,737 | +129.0% | 0.01% | +500.0% |
| Q4 2022 | $2,781 | -99.8% | 254,887 | +18.0% | 0.00% | -50.0% |
| Q3 2022 | $1,820,000 | +878.5% | 215,994 | +817.9% | 0.00% | – |
| Q2 2022 | $186,000 | -82.3% | 23,531 | -46.9% | 0.00% | -100.0% |
| Q1 2022 | $1,050,000 | -87.3% | 44,302 | -81.6% | 0.00% | -50.0% |
| Q4 2021 | $8,248,000 | +1157.3% | 241,194 | +551.9% | 0.00% | – |
| Q3 2021 | $656,000 | +97.0% | 36,997 | +399.6% | 0.00% | – |
| Q2 2021 | $333,000 | -66.1% | 7,405 | -80.4% | 0.00% | -100.0% |
| Q1 2021 | $981,000 | +358.4% | 37,866 | +257.0% | 0.00% | – |
| Q4 2020 | $214,000 | -24.6% | 10,608 | -27.0% | 0.00% | – |
| Q3 2020 | $284,000 | +27.9% | 14,527 | +15.4% | 0.00% | – |
| Q2 2020 | $222,000 | +428.6% | 12,591 | +113.7% | 0.00% | – |
| Q1 2020 | $42,000 | -67.7% | 5,893 | -68.1% | 0.00% | – |
| Q4 2019 | $130,000 | -25.3% | 18,454 | +27.3% | 0.00% | – |
| Q3 2019 | $174,000 | -42.4% | 14,498 | -41.9% | 0.00% | – |
| Q2 2019 | $302,000 | -62.8% | 24,975 | -61.3% | 0.00% | -100.0% |
| Q1 2019 | $812,000 | +75.8% | 64,569 | -5.9% | 0.00% | – |
| Q4 2018 | $462,000 | +181.7% | 68,602 | +179.7% | 0.00% | – |
| Q2 2018 | $164,000 | +60.8% | 24,527 | +106.5% | 0.00% | – |
| Q1 2018 | $102,000 | -40.4% | 11,877 | +44.6% | 0.00% | – |
| Q4 2017 | $171,000 | +4175.0% | 8,216 | +3703.7% | 0.00% | – |
| Q3 2017 | $4,000 | -20.0% | 216 | -53.4% | 0.00% | – |
| Q2 2017 | $5,000 | -75.0% | 464 | -71.6% | 0.00% | – |
| Q1 2017 | $20,000 | +300.0% | 1,635 | +650.0% | 0.00% | – |
| Q4 2016 | $5,000 | – | 218 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 750,632 | $7,724,000 | 26.59% |
| BVF INC/IL | 2,617,967 | $26,939,000 | 2.37% |
| GREAT POINT PARTNERS LLC | 982,449 | $10,109,000 | 1.58% |
| Alambic Investment Management, L.P. | 65,128 | $670,000 | 0.53% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,243,202 | $23,083,000 | 0.14% |
| ALGERT GLOBAL LLC | 44,477 | $458,000 | 0.10% |
| Monashee Investment Management LLC | 42,945 | $442,000 | 0.09% |
| Tekla Capital Management LLC | 219,042 | $2,254,000 | 0.08% |
| Spark Investment Management LLC | 138,800 | $1,428,000 | 0.08% |
| OXFORD ASSET MANAGEMENT LLP | 187,653 | $1,904,000 | 0.04% |